Repligen Corporation (RGEN)
Return on equity (ROE)
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Net income | US$ in thousands | 41,577 | 185,959 | 128,291 | 59,926 | 21,411 |
Total stockholders’ equity | US$ in thousands | 1,971,200 | 1,910,700 | 1,750,070 | 1,529,150 | 1,059,770 |
ROE | 2.11% | 9.73% | 7.33% | 3.92% | 2.02% |
December 31, 2023 calculation
ROE = Net income ÷ Total stockholders’ equity
= $41,577K ÷ $1,971,200K
= 2.11%
Over the past five years, Repligen Corp.'s return on equity (ROE) has exhibited a fluctuating trend, with values ranging from 2.02% to 9.73%. In 2023, the ROE decreased significantly to 2.11% from 9.73% in 2022, indicating a notable decline in profitability and efficiency in generating returns for shareholders' equity compared to the previous year.
The ROE of 2.11% in 2023 reflects that for every dollar of shareholders' equity invested in the company, Repligen Corp. generated a return of 2.11 cents. This level of return is relatively low and suggests that the company may not be effectively utilizing its equity to generate profits for shareholders.
Compared to the ROE levels in 2021 (7.33%) and 2022 (9.73%), the significant drop in 2023 could be a cause for concern as it indicates a potential decline in financial performance and efficiency. Investors and stakeholders may want to further investigate the reasons behind this decrease in ROE to assess the company's financial health and sustainability.
Overall, the consistent fluctuations in ROE over the past five years highlight the need for stakeholders to closely monitor Repligen Corp.'s financial performance and management of shareholder equity to ensure sustainable and improved returns in the future.
Peer comparison
Dec 31, 2023